Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse operating-status notice and the previous Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T12:11:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and operating status has been added, with guidance to opm.gov for updates. The page now shows a new revision tag (v3.4.1) replacing the previous (v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:36:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); core study content remains unchanged.
    Difference
    0.2%
    Check dated 2026-01-28T06:28:16.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision update shows Revision: v3.3.4, replacing the previous v3.3.3; no study details or eligibility information were changed.
    Difference
    0.1%
    Check dated 2026-01-14T03:38:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2, with no impact to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:15:12.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The Publications section now states that entries are auto-filled from PubMed and may not pertain to the study. It also adds the Revision: v3.3.2 label.
    Difference
    0.1%
    Check dated 2025-11-25T11:26:39.000Z thumbnail image

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.